Vimarsana
Biggest News Aggregation in the World

Page 7 - Thomas Otto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Otto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Otto Today - Breaking & Trending Today

Vetter Completes Integration of its Austrian Clinical Manufacturing Site - Vimarsana News

Vetter Completes Integration of its Austrian Clinical Manufacturing Site

Vetter Completes Integration of its Austrian Clinical Manufacturing Site Vetter Completes Integration of its Austrian Clinical Manufacturing Site One year after the purchase of the clinical manufacturing location in Rankweil, Austria, Vetter reports that all systems and processes have been successfully integrated. The site is now ready for operations. [Vetter Pharma International] July 21, 2021 One year after the purchase of the clinical manufacturing location in Rankweil, Austria, Vetter reports that all systems and processes have been successfully integrated. The site is now ready for oper...

Vetter Once Again Wins Axia Best Managed Companies Award - Vimarsana News

Vetter Once Again Wins Axia Best Managed Companies Award

Honor confirms continuity and the pharmaceutical service provider's approach to sustainabilityInternationally renowned seal of quality for exemplary corporate managementPositive assessment of strategy, innovation, culture and financeComprehensive, multi-stage application procedureRAVENSBURG, Germany, May 26, 2021 /...

Glasgow University and Eli Lilly hook up to discover and validate drug targets - Vimarsana News

Glasgow University and Eli Lilly hook up to discover and validate drug targets

The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate t

University of Glasgow teams up with Eli Lilly and Company for research on immunological diseases, including arthritis - Vimarsana News

University of Glasgow teams up with Eli Lilly and Company for research on immunological diseases, including arthritis

By Ian McConnell

UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets - Vimarsana News

UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets

Search jobs UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases. The £4.6million research collaboration, due to last four years, will work across four diseases – psoriatic arthritis, rheumatoid arthritis, fibrosis and vasculitis – and will be led by the University of Glasgow’s Institute of Infection, Immunity and...